Intravascular Microaxial Left Ventricular Assist Device Manufacturer Payments to Cardiologists and Use of Devices
- Government
- 179
Mechanical circulatory support devices are increasingly used by physicians for patients receiving percutaneous coronary intervention (PCI). Use of intra-aortic balloon pumps (IABPs) has decreased, whereas use of intravascular microaxial left ventricular assist devices (LVADs) grew from 4.1% to 9.8% of all PCIs for acute myocardial infarction complicated by cardiogenic shock from 2015 to 2017, despite limited evidence demonstrating safety or clinical effectiveness and higher cost. Payments—even relatively small payments—from industry to physicians have been associated with greater likelihood of brand-name drug prescribing and medical device use. The study examined whether payments from the LVAD manufacturer to cardiologists performing PCI were associated with any use of LVADs.
Never miss a thing! Sign up for our newsletter to stay updated.
Provider Strategy reports on market developments and insights related to the healthcare provider workforce. Our publication is committed to improving the healthcare professional workforce, utilization of providers, and ultimately supporting thought leadership in workforce innovation.
We are brought to you by the American Association of Provider Compensation Professionals.